{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:36:24Z","timestamp":1792787784072,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Edmond J. Safra Center for Bioinformatics at Tel-Aviv University"},{"name":"Israel Science Foundation","award":["ISF 1286\/21"],"award-info":[{"award-number":["ISF 1286\/21"]}],"id":[{"id":"https:\/\/ror.org\/04sazxf24","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Res Methodol"],"DOI":"10.1186\/s12874-026-02947-5","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:14:20Z","timestamp":1784542460000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Estimating treatment effects from non-overlapping cohorts with application to antimicrobial resistance"],"prefix":"10.1186","volume":"26","author":[{"given":"Avi","family":"Baraz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Nevo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amos","family":"Cahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tal","family":"Brosh-Nissimov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Chowers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7594-9745","authenticated-orcid":false,"given":"Uri","family":"Obolski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"2947_CR1","unstructured":"Hern\u00e1n MA, Robins JM. Causal Inference: What If. Boca Raton, FL: Chapman & Hall\/CRC; 2020. https:\/\/miguelhernan.org\/whatifbook"},{"issue":"6","key":"2947_CR2","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1093\/aje\/kwp436","volume":"171","author":"D Westreich","year":"2010","unstructured":"Westreich D, Cole SR. Invited commentary: positivity in practice. Am J Epidemiol. 2010;171(6):674\u20137. https:\/\/doi.org\/10.1093\/aje\/kwp436.","journal-title":"Am J Epidemiol"},{"issue":"2","key":"2947_CR3","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1214\/18-AOAS1231","volume":"13","author":"RC Nethery","year":"2019","unstructured":"Nethery RC, Mealli F, Dominici F. Estimating population average causal effects in the presence of non-overlap: the effect of natural gas compressor station exposure on cancer mortality. Ann Appl Stat. 2019;13(2):1242\u201367. https:\/\/doi.org\/10.1214\/18-AOAS1231. PubMedPMID:31346355;PubMedCentralPMCID:PMC6658123.","journal-title":"Ann Appl Stat"},{"issue":"11","key":"2947_CR4","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1002\/pds.5338","volume":"30","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, Hubbard RA, Chubak J, Roy J, Mitra N. Core concepts in pharmacoepidemiology: violations of the positivity assumption in the causal analysis of observational data: consequences and statistical approaches. Pharmacoepidemiol Drug Saf. 2021;30(11):1471\u201385. https:\/\/doi.org\/10.1002\/pds.5338.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"2947_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/sim.9600","volume":"42","author":"AY Zhu","year":"2023","unstructured":"Zhu AY, Mitra N, Roy J. Addressing positivity violations in causal effect estimation using Gaussian process priors. Stat Med. 2023;42(1):33\u201351. https:\/\/doi.org\/10.1002\/sim.9600.","journal-title":"Stat Med"},{"issue":"3","key":"2947_CR6","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/aje\/kwab263","volume":"191","author":"SJ Newsome","year":"2022","unstructured":"Newsome SJ, Daniel RM, Carr SB, Bilton D, Keogh RH. Using negative control outcomes and difference-in-differences analysis to estimate treatment effects in an entirely treated cohort: the effect of Ivacaftor in cystic fibrosis. Am J Epidemiol. 2022;191(3):505\u201315. https:\/\/doi.org\/10.1093\/aje\/kwab263.","journal-title":"Am J Epidemiol"},{"issue":"4","key":"2947_CR7","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1007\/s12668-019-00658-4","volume":"9","author":"A Talebi Bezmin Abadi","year":"2019","unstructured":"Talebi Bezmin Abadi A, Rizvanov AA, Haertl\u00e9 T, Blatt NL. World Health Organization report: current crisis of antibiotic resistance. BioNanoSci. 2019;9(4):778\u201388. https:\/\/doi.org\/10.1007\/s12668-019-00658-4.","journal-title":"BioNanoSci"},{"issue":"12","key":"2947_CR8","doi-asserted-by":"publisher","first-page":"e368","DOI":"10.1016\/S1473-3099(18)30296-2","volume":"18","author":"A Chatterjee","year":"2018","unstructured":"Chatterjee A, Modarai M, Naylor NR, Boyd SE, Atun R, Barlow J, et al. Quantifying drivers of antibiotic resistance in humans: a systematic review. Lancet Infect Dis. 2018;18(12):e368\u201378. https:\/\/doi.org\/10.1016\/S1473-3099(18)30296-2.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"2947_CR9","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.ijantimicag.2017.12.013","volume":"51","author":"E Carrara","year":"2018","unstructured":"Carrara E, Pfeffer I, Zusman O, Leibovici L, Paul M. Determinants of inappropriate empirical antibiotic treatment: systematic review and meta-analysis. Int J Antimicrob Agents. 2018;51(4):548\u201353. https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.12.013.","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"2947_CR10","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.mayocp.2018.11.005","volume":"94","author":"EP Lesho","year":"2019","unstructured":"Lesho EP, Laguio-Vila M. The slow-motion catastrophe of antimicrobial resistance and practical interventions for all prescribers. Mayo Clin Proc. 2019;94(6):1040\u20137. https:\/\/doi.org\/10.1016\/j.mayocp.2018.11.005.","journal-title":"Mayo Clin Proc"},{"issue":"10014","key":"2947_CR11","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S0140-6736(15)00473-0","volume":"387","author":"AH Holmes","year":"2016","unstructured":"Holmes AH, Moore LSP, Sundsfjord A, Steinbakk M, Regmi S, Karkey A, et al. Understanding the mechanisms and drivers of antimicrobial resistance. The Lancet. 2016;387(10014):176\u201387. https:\/\/doi.org\/10.1016\/S0140-6736(15)00473-0.","journal-title":"The Lancet"},{"issue":"4","key":"2947_CR12","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3201\/eid0804.010312","volume":"8","author":"M Lipsitch","year":"2002","unstructured":"Lipsitch M, Samore MH. Antimicrobial use and antimicrobial resistance: a population perspective. Emerg Infect Dis. 2002;8(4):347\u201354. https:\/\/doi.org\/10.3201\/eid0804.010312.","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"2947_CR13","doi-asserted-by":"publisher","first-page":"649.e1","DOI":"10.1016\/j.cmi.2015.03.013","volume":"21","author":"E Weiss","year":"2015","unstructured":"Weiss E, Zahar JR, Lesprit P, Ruppe E, Leone M, Chastre J, et al. Elaboration of a consensual definition of de-escalation allowing a ranking of \u03b2-lactams. Clin Microbiol Infect. 2015;21(7):649.e1-649.e10. https:\/\/doi.org\/10.1016\/j.cmi.2015.03.013.","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"2947_CR14","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1086\/677633","volume":"35","author":"K Madaras-Kelly","year":"2014","unstructured":"Madaras-Kelly K, Jones M, Remington R, Hill N, Huttner B, Samore M. Development of an antibiotic spectrum score based on veterans affairs culture and susceptibility data for the purpose of measuring antibiotic de-escalation: a modified delphi approach. Infect Control Hosp Epidemiol. 2014;35(9):1103\u201313. https:\/\/doi.org\/10.1086\/677633.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2947_CR15","unstructured":"World Health Organization. The selection and use of essential medicines: report of the WHO Expert Committee on Selection and Use of Essential Medicines, 2023 (including the 23rd WHO Model List of Essential Medicines and the 9th WHO Model List of Essential Medicines for Children). Geneva: World Health Organization; 2024. (WHO technical report series;1049). https:\/\/iris.who.int\/handle\/10665\/376570"},{"key":"2947_CR16","doi-asserted-by":"publisher","unstructured":"Zehavi T, Obolski U, Chowers M, Nevo D. Causal effects on non-terminal event time with application to antibiotic usage and future resistance. arXiv; 2025. https:\/\/doi.org\/10.48550\/arXiv.2506.09624. Cited 11 Sep 2025.","DOI":"10.48550\/arXiv.2506.09624"},{"key":"2947_CR17","doi-asserted-by":"publisher","unstructured":"Chowers M, Zehavi T, Gottesman BS, Baraz A, Nevo D, Obolski U. Estimating the impact of cefuroxime versus cefazolin and amoxicillin\/clavulanate use on future collateral resistance: a retrospective comparison. Journal of Antimicrobial Chemotherapy. 2022;77(7):1992\u20135. https:\/\/doi.org\/10.1093\/jac\/dkac130.","DOI":"10.1093\/jac\/dkac130"},{"issue":"1","key":"2947_CR18","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-025-56287-x","volume":"16","author":"Y Saciuk","year":"2025","unstructured":"Saciuk Y, Nevo D, Chowers M, Obolski U. Penicillin allergy as an instrumental variable for estimating antibiotic effects on resistance. Nat Commun. 2025;16(1):1088. https:\/\/doi.org\/10.1038\/s41467-025-56287-x.","journal-title":"Nat Commun"},{"issue":"3","key":"2947_CR19","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.cmi.2025.11.013","volume":"32","author":"M Chowers","year":"2026","unstructured":"Chowers M, Atias D, Gottesman B, Low M, Obolski U. Estimating antibiotic resistance following antibiotic treatment in outpatients: a retrospective study. Clin Microbiol Infect. 2026;32(3):446\u201352. https:\/\/doi.org\/10.1016\/j.cmi.2025.11.013.","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"2947_CR20","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1177\/8755122517720293","volume":"33","author":"SH Durham","year":"2017","unstructured":"Durham SH, Wingler MJ, Eiland LS. Appropriate use of ceftriaxone in the emergency department of a veteran\u2019s health care system. J Pharm Technol. 2017;33(6):215\u20138. https:\/\/doi.org\/10.1177\/8755122517720293.","journal-title":"J Pharm Technol"},{"issue":"4","key":"2947_CR21","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3904\/kjim.2009.24.4.374","volume":"24","author":"H Lee","year":"2009","unstructured":"Lee H, Jung D, Yeom JS, Son JS, Jung SI, Kim YS, et al. Evaluation of ceftriaxone utilization at multicenter study. Kor J Intern Med. 2009;24(4):374. https:\/\/doi.org\/10.3904\/kjim.2009.24.4.374.","journal-title":"Kor J Intern Med"},{"issue":"1","key":"2947_CR22","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12879-018-2960-9","volume":"18","author":"S Bischoff","year":"2018","unstructured":"Bischoff S, Walter T, Gerigk M, Ebert M, Vogelmann R. Empiric antibiotic therapy in urinary tract infection in patients with risk factors for antibiotic resistance in a German emergency department. BMC Infect Dis. 2018;18(1):56. https:\/\/doi.org\/10.1186\/s12879-018-2960-9.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"2947_CR23","doi-asserted-by":"publisher","first-page":"469","DOI":"10.2165\/00003495-198427060-00001","volume":"27","author":"DM Richards","year":"1984","unstructured":"Richards DM, Heel RC, Brogden RN, Speight TM, Avery GS. Ceftriaxone a review of its antibacterial activity, pharmacological properties and therapeutic use. Drugs. 1984;27(6):469\u2013527. https:\/\/doi.org\/10.2165\/00003495-198427060-00001.","journal-title":"Drugs"},{"issue":"3","key":"2947_CR24","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1099\/jmm.0.001138","volume":"69","author":"S Th\u00f8nnings","year":"2020","unstructured":"Th\u00f8nnings S, Jensen KS, Nielsen NB, Skj\u00f8nnemand M, Hansen DS, Lange KHW, et al. Cefuroxime pharmacokinetics and pharmacodynamics for intravenous dosage regimens with 750 mg or 1500 mg doses in healthy young volunteers. J Med Microbiol. 2020;69(3):387\u201395. https:\/\/doi.org\/10.1099\/jmm.0.001138. PubMed PMID: 31958049.","journal-title":"J Med Microbiol"},{"issue":"4","key":"2947_CR25","first-page":"167","volume":"26","author":"JM Brogard","year":"1988","unstructured":"Brogard JM, Blickle JF, Jehl F, Arnaud JP, Paris-Bockel D, Monteil H. High biliary elimination of ceftriaxone in man. Int J Clin Pharmacol Ther Toxicol. 1988;26(4):167\u201372 PubMed PMID: 3403093.","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"issue":"3","key":"2947_CR26","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s10096-018-3186-x","volume":"37","author":"V de Lastours","year":"2018","unstructured":"de Lastours V, Goulenok T, Gu\u00e9rin F, Jacquier H, Eyma C, Chau F, et al. Ceftriaxone promotes the emergence of AmpC-overproducing Enterobacteriaceae in gut microbiota from hospitalized patients. Eur J Clin Microbiol Infect Dis. 2018;37(3):417\u201321. https:\/\/doi.org\/10.1007\/s10096-018-3186-x. PubMed PMID: 29318461.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"11","key":"2947_CR27","doi-asserted-by":"publisher","first-page":"e00473","DOI":"10.1128\/aac.00473-17","volume":"61","author":"J Meletiadis","year":"2017","unstructured":"Meletiadis J, Turlej-Rogacka A, Lerner A, Adler A, Tacconelli E, Mouton JW. Amplification of antimicrobial resistance in gut flora of patients treated with ceftriaxone. Antimicrob Agents Chemother. 2017;61(11):e00473-e517. https:\/\/doi.org\/10.1128\/aac.00473-17.","journal-title":"Antimicrob Agents Chemother"},{"key":"2947_CR28","doi-asserted-by":"publisher","unstructured":"Full article: Pre-existing \u03b2-lactamase gene diversity is associated with lower risk of ESBL-producing Enterobacterales colonization in patients exposed to ceftriaxone. https:\/\/doi.org\/10.1080\/19490976.2026.2627692. Cited 30\u00a0 Apr 2026.","DOI":"10.1080\/19490976.2026.2627692"},{"issue":"4","key":"2947_CR29","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1365-2710.2007.00836.x","volume":"32","author":"K Urb\u00e1nek","year":"2007","unstructured":"Urb\u00e1nek K, Kol\u00e1\u0159 M, Love\u010dkov\u00e1 Y, Strojil J, \u0160antav\u00e1 L. Influence of third-generation cephalosporin utilization on the occurrence of ESBL-positive Klebsiella pneumoniae strains. J Clin Pharm Ther. 2007;32(4):403\u20138. https:\/\/doi.org\/10.1111\/j.1365-2710.2007.00836.x.","journal-title":"J Clin Pharm Ther"},{"issue":"Supplement_1","key":"2947_CR30","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1086\/521859","volume":"46","author":"RC Owens Jr","year":"2008","unstructured":"Owens RC Jr, Donskey CJ, Gaynes RP, Loo VG, Muto CA. Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis. 2008;46(Supplement_1):S19-31. https:\/\/doi.org\/10.1086\/521859.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"2947_CR31","doi-asserted-by":"publisher","first-page":"e02169","DOI":"10.1128\/aac.02169-19","volume":"64","author":"BJ Webb","year":"2020","unstructured":"Webb BJ, Subramanian A, Lopansri B, Goodman B, Jones PB, Ferraro J, et al. Antibiotic exposure and risk for hospital-associated Clostridioides difficile infection. Antimicrob Agents Chemother. 2020;64(4):e02169-e2219. https:\/\/doi.org\/10.1128\/aac.02169-19.","journal-title":"Antimicrob Agents Chemother"},{"key":"2947_CR32","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9781139025751","volume-title":"Causal inference for statistics, social, and biomedical sciences: an introduction","author":"G Imbens","year":"2015","unstructured":"Imbens G, Rubin D. Causal inference for statistics, social, and biomedical sciences: an introduction. 2015."},{"issue":"3","key":"2947_CR33","doi-asserted-by":"publisher","first-page":"390.e1","DOI":"10.1016\/j.cmi.2022.10.021","volume":"29","author":"A Baraz","year":"2023","unstructured":"Baraz A, Chowers M, Nevo D, Obolski U. The time-varying association between previous antibiotic use and antibiotic resistance. Clin Microbiol Infect. 2023;29(3):390.e1-390.e4. https:\/\/doi.org\/10.1016\/j.cmi.2022.10.021.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"2947_CR34","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12916-018-1109-4","volume":"16","author":"M Bakhit","year":"2018","unstructured":"Bakhit M, Hoffmann T, Scott AM, Beller E, Rathbone J, Del Mar C. Resistance decay in individuals after antibiotic exposure in primary care: a systematic review and meta-analysis. BMC Med. 2018;16(1):126. https:\/\/doi.org\/10.1186\/s12916-018-1109-4.","journal-title":"BMC Med"},{"issue":"340","key":"2947_CR35","doi-asserted-by":"publisher","first-page":"c2096","DOI":"10.1136\/bmj.c2096","volume":"18","author":"C Costelloe","year":"2010","unstructured":"Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ. 2010;18(340):c2096. https:\/\/doi.org\/10.1136\/bmj.c2096. PubMed PMID: 20483949.","journal-title":"BMJ"},{"key":"2947_CR36","unstructured":"Arumugham VB, Gujarathi R, Cascella M. Third-Generation Cephalosporins. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK549881\/ PubMed PMID: 31751071. Cited 15\u00a0 Sep 2025."},{"issue":"4","key":"2947_CR37","doi-asserted-by":"publisher","first-page":"115171","DOI":"10.1016\/j.diagmicrobio.2020.115171","volume":"98","author":"AA Bhalodi","year":"2020","unstructured":"Bhalodi AA, Magnano P, Humphries RM. Performance of ceftriaxone susceptibility testing on the Accelerate Pheno\u00ae system of ESBL-producing isolates. Diagn Microbiol Infect Dis. 2020;98(4):115171. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2020.115171.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2947_CR38","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511803161","volume-title":"Causality","author":"J Pearl","year":"2009","unstructured":"Pearl J. Causality. Cambridge university press; 2009."},{"issue":"1","key":"2947_CR39","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/00001648-199901000-00008","volume":"10","author":"S Greenland","year":"1999","unstructured":"Greenland S, Pearl J, Robins JM. Causal diagrams for epidemiologic research. Epidemiology. 1999;10(1):37\u201348.","journal-title":"Epidemiology"},{"issue":"3","key":"2947_CR40","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/EDE.0b013e3181d61eeb","volume":"21","author":"M Lipsitch","year":"2010","unstructured":"Lipsitch M, Tchetgen Tchetgen E, Cohen T. Negative controls: a tool for detecting confounding and bias in observational studies. Epidemiology. 2010;21(3):383\u20138. https:\/\/doi.org\/10.1097\/EDE.0b013e3181d61eeb.","journal-title":"Epidemiology"},{"issue":"4","key":"2947_CR41","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s40471-020-00243-4","volume":"7","author":"X Shi","year":"2020","unstructured":"Shi X, Miao W, Tchetgen ET. A selective review of negative control methods in epidemiology. Curr Epidemiol Rep. 2020;7(4):190\u2013202. https:\/\/doi.org\/10.1007\/s40471-020-00243-4.","journal-title":"Curr Epidemiol Rep"},{"key":"2947_CR42","doi-asserted-by":"publisher","unstructured":"Danieli O, Nevo D, Walk I, Weinstein B, Zeltzer D. Negative control falsification tests for instrumental variable designs. arXiv; 2024. https:\/\/doi.org\/10.48550\/arXiv.2312.15624. Cited 9 Mar 2025.","DOI":"10.48550\/arXiv.2312.15624"},{"issue":"1","key":"2947_CR43","doi-asserted-by":"publisher","first-page":"12472","DOI":"10.1038\/s41598-021-91905-w","volume":"11","author":"DE Foudraine","year":"2021","unstructured":"Foudraine DE, Strepis N, Stingl C, Ten Kate MT, Verbon A, Klaassen CHW, et al. Exploring antimicrobial resistance to beta-lactams, aminoglycosides and fluoroquinolones in E. coli and K. pneumoniae using proteogenomics. Sci Rep. 2021;11(1):12472. https:\/\/doi.org\/10.1038\/s41598-021-91905-w.","journal-title":"Sci Rep"},{"issue":"12","key":"2947_CR44","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.3390\/pathogens10121638","volume":"10","author":"KA Glen","year":"2021","unstructured":"Glen KA, Lamont IL. \u03b2-lactam resistance in Pseudomonas aeruginosa: current status, future prospects. Pathogens. 2021;10(12):1638. https:\/\/doi.org\/10.3390\/pathogens10121638.","journal-title":"Pathogens"},{"issue":"3","key":"2947_CR45","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3390\/pharmacy7030103","volume":"7","author":"SB Chaudhry","year":"2019","unstructured":"Chaudhry SB, Veve MP, Wagner JL. Cephalosporins: a focus on side chains and \u03b2-lactam cross-reactivity. Pharmacy (Basel). 2019;7(3):103. https:\/\/doi.org\/10.3390\/pharmacy7030103.","journal-title":"Pharmacy (Basel)"},{"issue":"5","key":"2947_CR46","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.jemermed.2011.05.035","volume":"42","author":"JD Campagna","year":"2012","unstructured":"Campagna JD, Bond MC, Schabelman E, Hayes BD. The use of cephalosporins in penicillin-allergic patients: a literature review. J Emerg Med. 2012;42(5):612\u201320. https:\/\/doi.org\/10.1016\/j.jemermed.2011.05.035.","journal-title":"J Emerg Med"},{"key":"2947_CR47","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/978-1-4757-1229-2_14","volume-title":"AIDS epidemiology [Internet]","author":"JM Robins","year":"1992","unstructured":"Robins JM, Rotnitzky A. Recovery of information and adjustment for dependent censoring using surrogate markers. In: Jewell NP, Dietz K, Farewell VT, editors. AIDS epidemiology [Internet]. Boston, MA: Birkh\u00e4user Boston; 1992. p. 297\u2013331. https:\/\/doi.org\/10.1007\/978-1-4757-1229-2_14."},{"issue":"5","key":"2947_CR48","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1080\/10543406.2020.1757692","volume":"30","author":"G Dong","year":"2020","unstructured":"Dong G, Mao L, Huang B, Gamalo-Siebers M, Wang J, Yu G, et al. The inverse-probability-of-censoring weighting (IPCW) adjusted win ratio statistic: an unbiased estimator in the presence of independent censoring. J Biopharm Stat. 2020;30(5):882\u201399. https:\/\/doi.org\/10.1080\/10543406.2020.1757692.","journal-title":"J Biopharm Stat"},{"key":"2947_CR49","doi-asserted-by":"publisher","unstructured":"Michal C, Dor A, Batsheva G, Marcelo L, Uri O. Estimating antibiotic resistance following antibiotic treatment in outpatients: a retrospective study. Clin Microbiol Infect 2025;S1198743X25005683. https:\/\/doi.org\/10.1016\/j.cmi.2025.11.013.","DOI":"10.1016\/j.cmi.2025.11.013"},{"issue":"4","key":"2947_CR50","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S1473-3099(18)30676-5","volume":"19","author":"M Low","year":"2019","unstructured":"Low M, Neuberger A, Hooton TM, Green MS, Raz R, Balicer RD, et al. Association between urinary community-acquired fluoroquinolone-resistant Escherichia coli and neighbourhood antibiotic consumption: a population-based case-control study. Lancet Infect Dis. 2019;19(4):419\u201328. https:\/\/doi.org\/10.1016\/S1473-3099(18)30676-5. PubMed PMID: 30846277.","journal-title":"Lancet Infect Dis"},{"key":"2947_CR51","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.microc.2017.02.006","volume":"136","author":"P Grenni","year":"2018","unstructured":"Grenni P, Ancona V, Barra Caracciolo A. Ecological effects of antibiotics on natural ecosystems: a review. Microchem J. 2018;136:25\u201339. https:\/\/doi.org\/10.1016\/j.microc.2017.02.006.","journal-title":"Microchem J"},{"issue":"3","key":"2947_CR52","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1093\/cid\/ciz858","volume":"71","author":"BS Gottesman","year":"2020","unstructured":"Gottesman BS, Low M, Almog R, Chowers M. Quinolone consumption by mothers increases their children\u2019s risk of acquiring quinolone-resistant bacteriuria. Clin Infect Dis. 2020;71(3):532\u20138. https:\/\/doi.org\/10.1093\/cid\/ciz858.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2947_CR53","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/EDE.0b013e3182319159","volume":"23","author":"B Chaix","year":"2012","unstructured":"Chaix B, Evans D, Merlo J, Suzuki E. Commentary: weighing up the dead and missing reflections on inverse-probability weighting and principal stratification to address truncation by death. Epidemiology. 2012;23(1):129\u201331. https:\/\/doi.org\/10.1097\/EDE.0b013e3182319159.","journal-title":"Epidemiology"},{"issue":"1","key":"2947_CR54","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.0006-341X.2002.00021.x","volume":"58","author":"CE Frangakis","year":"2002","unstructured":"Frangakis CE, Rubin DB. Principal stratification in causal inference. Biometrics. 2002;58(1):21\u20139. https:\/\/doi.org\/10.1111\/j.0006-341X.2002.00021.x.","journal-title":"Biometrics"},{"key":"2947_CR55","doi-asserted-by":"publisher","unstructured":"Halekoh U, H\u00f8jsgaard S, Yan J. The R package geepack for generalized estimating equations. J Stat Soft. 2006;15(2). https:\/\/doi.org\/10.18637\/jss.v015.i02.","DOI":"10.18637\/jss.v015.i02"}],"container-title":["BMC Medical Research Methodology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12874-026-02947-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12874-026-02947-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12874-026-02947-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:23:42Z","timestamp":1792056222000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12874-026-02947-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2947"],"URL":"https:\/\/doi.org\/10.1186\/s12874-026-02947-5","relation":{},"ISSN":["1471-2288"],"issn-type":[{"value":"1471-2288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"19 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki. The study was approved by the Institutional Review Board Committees of Meir Medical Center (reference no. MMC-0143\u201319) and Samson Assuta Ashdod Hospital (reference no. AAA-0071\u201322). Since this was a retrospective study using anonymized, archived medical records, an exemption from informed consent was granted by the committees.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"219"}}